Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06511505 · ClinicalTrials.gov registry record · NA
NOrthwestern Tempus AI-enaBLed Electrocardiography (NOTABLE) Trial
A NA study, sponsored by Northwestern University.
- Not yet
- Registry status
- NA
- Development phase
- 1,000
- Enrollment target
NCT06511505 is a NA study that has not yet begun recruiting, run by Northwestern University. The registered enrollment target is 1,000 participants.
The verdict
NCT06511505, a NA study, has not yet begun recruiting, sponsored by Northwestern University.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 1,000 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to determine if a machine learning/artificial intelligence (AI)-based electrocardiogram (ECG) algorithm (Tempus Next software) can identify undiagnosed cardiovascular disease in patients. It will also examine the safety and effectiveness of using this AI-based tool in a clinical setting. The main questions it aims to answer are: 1. Can the AI-based ECG algorithm improve the detection of atrial fibrillation and structural heart disease? 2. How does the use of this algorithm affect clinical decision-making and patient outcomes? Researchers will compare the outcomes of healthcare providers who receive the AI-based ECG results to those who do not. Participants (healthcare providers) will: Be randomized into two groups: one that receives AI-based ECG results and one that does not. In the intervention group, receive an assessment of their patient's risk of atrial fibrillation or structural heart disease with each ordered ECG. Decide whether to perform further clinical evaluation based on the AI-generated risk assessment as part of routine clinical care.
Interventions
- OTHER TEMPUS AI-enabled ECG-based Screening Tool
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2024-08-03 |
| Est. Completion | 2026-02-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06511505
The ClinicalTrials.gov registry entry for NCT06511505 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which TEMPUS AI-enabled ECG-based Screening Tool is the first listed.
NCT06511505 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06511505 about?
NCT06511505 is a clinical study titled "NOrthwestern Tempus AI-enaBLed Electrocardiography (NOTABLE) Trial". The goal of this clinical trial is to determine if a machine learning/artificial intelligence (AI)-based electrocardiogram (ECG) algorithm (Tempus Next software) can identify undiagnosed cardiovascular disease in patients. It will also examine the safety and effectiveness of using this AI-based tool...
What is the current status of trial NCT06511505?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 1,000 participants. The study started on 2024-08-03. Estimated completion is 2026-02-03.
What interventions are being tested in trial NCT06511505?
The interventions under investigation include: TEMPUS AI-enabled ECG-based Screening Tool (OTHER).
Who is sponsoring clinical trial NCT06511505?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.